First-line bevacizumab-containing therapy for HER2-negative locally advanced/metastatic breast cancer: real-world experience from >2000 patients treated in the multicentre AVANTI study - Müller, Volkmar; Ruhnke, Markus; Hoffmann, Oliver; Grafe, Andrea; Tomé, Oliver; Fett, Werner; Bruch, Harald-Robert; Sommer-Joos, Ann-Katrin; Schneeweiss, Andreas (The breast, 2021)
Online veröffenticht am 27. August 2021, Artikelversion vom 3. September 2021